Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation
Company Logo

Destroying Cancer at the Speed of Light®

Clinical Study Underway (68 of 100 Patients Treated)
Expected to complete enrollment at the end of 2024
Expected to complete study at the end of 2026


Bullboard - Investor Discussion Forum Theralase Technologies Inc. V.TLT

Alternate Symbol(s):  V.TLT.WT | TLTFF

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called... see more

TSXV:TLT - Post Discussion

View:
Post by skys1 on Jul 01, 2023 10:08am

Miniature PP

IMO, this very small PP will only last them 4 months or so which is very bullish as it indicates they expect something to happen soon. I believe this new member of the BOD is very strategic, because current management doesn't have much expience in the Pharma deal marking area. She has been involved in several Pharma deals, so she knows her way around this scene.
Comment by steamfitter on Jul 01, 2023 6:52pm
With the good news coming out all those 35 cent warrents will be cashing in. Theralase is heading to  Commercialization of Bladder Cancer Cure.  Just my opinion and thoughts of where we are. CDC has asked for more patients and I am sure they will able to prove our product beats anything on the market now.
Comment by chry200030 on Jul 01, 2023 8:18pm
Correct. Those .35 warrants will be way in the money before they are set to expire in August 2024.  Excellent buy at this price. but not to expect this price to last long.
Comment by fecats on Jul 02, 2023 12:21pm
Don't forget that there is also just over 4 million warrants at .50 for Oct 3/23 . Roger has close to a million of these . They have already been extended twice , so can't be again. Don't think he will want to lose those . But is there enough positive developments to get stock well over .50 by then ? Will also bring company about 2 million bucks . Will be interesting to see
Comment by patience69 on Jul 02, 2023 12:27pm
Good point fe. Maybe those warrants could even be re-priced to help bring in the $$$.  Dropping them to 35 cents could still bring in almost 1.5 M (more than the recent financing). I guess it all depends on a few things
Comment by Yajne on Jul 02, 2023 2:18pm
....warrants re-priced? Huh? I'd be surprised if theyre allowed to do that patience69
Comment by patience69 on Jul 02, 2023 2:46pm
It is something that legally can be done with the exchange"s permission. The beauty of that is no further dilution. It would not add to the fully diluted share count. Better for the company than another raise that dilutes
Comment by O12009 on Jul 02, 2023 5:56pm
Of course if the warrant is in the money there would be no reason to lower the strike price.
Comment by patience69 on Jul 02, 2023 6:00pm
Of course O12 thats the best case scenario
Comment by 99942Apophis on Jul 02, 2023 12:57pm
There will be in my opinion enough positive news out by Oct 3/23 fecats as BTD should be approved and of course higher CR patient data update without question. Perhaps by October we might be told of the first of a big pharmas finalized agreement but October could still be too early for that.  As I have speculated a $3 to $5 Canadian is strongly possible by year end as Mutual Funds and large ...more  
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.


Connect with V.TLT



Investor Presentation

View the Presentation

FACT SHEET

View the Presentation

The Watchlist

The Watchlist
{{currentVideo.videoCaption}}
< Previous Video {{moreVideoText}} Next Video >

Investment Opportunity

The Road to Saving Lives: Clinical Study Underway

  • Clinical Study with 68 of 100 Patients Treated (Enrollment to be completed by end of 2024, with study completed by end of 2026)
     
  • Ground Floor Investment Opportunity in Multi-Billion Dollar Industry
     
  • Best-in-class treatment for NMIBC (according to interim clinical data)
     
  • NMIBC (Non-Muscle-Invasive Bladder Cancer)
     

Facebook

Contact Us

Address:
41 Hollinger Road
Toronto, ON M4B 3G4
Canada

Toll Free:
1-866-THE-LASE (843-5273)
Local Phone:
416-699-LASE (5273)

Email:
info@theralase.com

Fax:
416-699-5250